The Real Brokerage Inc.
NASDAQ:REAXReal Estate - Services
+$0.05 today
- Market cap
- $353.94M
- Beta
- 0.74
- P/E (TTM)
- -59.9
- EPS (TTM)
- -$0.03
Volume 1.14M
Average 3.11M
REAX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
The Real Brokerage Inc.NASDAQ: REAX
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development grows, but more slowly than its trailing trend
Q1 FY2026 research & development of $5.15M rose 30.9% year over year, behind the +36.9% change in trailing-twelve-month research & development. Sequentially, it rose 7.1% from the prior quarter. Over 3 fiscal years it compounded at +53.0% a year.
Context
- Research & development amounted to 0.9% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +30.9% toward the trailing-twelve-month pace of +36.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 17.44M USD
- Year-over-year change
- +43.5%
- 4-year CAGR
- +44.7%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 17.44M | +43.5% |
| FY2024 | 2024-12-31 | 12.16M | +65.2% |
| FY2023 | 2023-12-31 | 7.36M | +51.2% |
| FY2022 | 2022-12-31 | 4.87M | +22.3% |
| FY2021 | 2021-12-31 | 3.98M | — |
Research & Development vs competitors
How REAX compares with its peers on the latest reported figures
- REAX's LTM Mar 2026 research & development of $18.66M is the highest of the 10 companies compared; the peer median is $0.
- Research & development amounts to 0.9% of revenue for REAX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $18.66M | +36.9% | +53.0% | 0.9% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
HBNBHotel101 Global Holdings Corp. Class A Ordinary Shares | FY2025 | $0 | — | — | 0.0% |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding REAX) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for REAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 121.68M | 381.76M | 689.16M | 1.26B | 1.97B |
| Cost of Revenue | 110.59M | 349.81M | 626.29M | 1.15B | 1.8B |
| Gross Profit | 11.09M | 31.95M | 62.87M | 114.74M | 163.76M |
| Gross Margin | 9.1% | 8.4% | 9.1% | 9.1% | 8.3% |
| Research & Development | 3.98M | 4.87M | 7.36M | 12.16M | 17.44M |
| Selling, General & Admin | 18.38M | 46.83M | 81.52M | 117.17M | 154.81M |
| Operating Expenses | 22.11M | 51.12M | 88.88M | 139.97M | 172.26M |
| Depreciation & Amortization | 213K | 333K | 1.13M | 1.4M | 1.93M |
| EBITDA | (11.05M) | (19.55M) | (25.49M) | (24.68M) | (6.57M) |
| EBITDA Margin | -9.1% | -5.1% | -3.7% | -2.0% | -0.3% |
| Operating Income | (11.02M) | (19.17M) | (26.01M) | (25.23M) | (8.5M) |
| Operating Margin | -9.1% | -5.0% | -3.8% | -2.0% | -0.4% |
| Interest Income | 13K | 0 | 0 | 0 | 0 |
| Interest Expense | 101K | 940K | 68K | 1.12M | 554K |
| Other Income / Expenses | (413K) | (589K) | (1.21M) | (1.23M) | (309K) |
| Income Before Tax | (11.68M) | (20.34M) | (27.22M) | (26.45M) | (8.81M) |
| Pre-Tax Margin | -9.6% | -5.3% | -3.9% | -2.1% | -0.4% |
| Income Tax Expense | 0 | 0 | 0 | 0 | (740K) |
| Net Income | (12.34M) | (20.58M) | (27.5M) | (26.54M) | (8.11M) |
| Net Margin | -10.1% | -5.4% | -4.0% | -2.1% | -0.4% |
| EPS (Basic) | (0.07) | (0.12) | (0.15) | (0.14) | (0.04) |
| EPS (Diluted) | (0.07) | (0.12) | (0.15) | (0.14) | (0.04) |
| Weighted Avg Shares | 175.27M | 178.2M | 178.13M | 191.17M | 219.87M |
| Weighted Avg Shares (Diluted) | 178.98M | 178.2M | 178.13M | 191.17M | 219.87M |
The Real Brokerage Inc.
NASDAQ:REAX
Intrinsic Alpha fair value
Locked
Current Price
$9.33
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.